 The above list of factors is not exhaustive The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations. S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 15.2% 12 – 16% Global Specialty Engineered Materials 1.1% 11.8% 12 – 16% Designed Structures & Solutions -- 7.1% 8 – 10% Performance Products & Solutions 5.5% 8.0% 9 – 12% Distribution 2.6% 6.0% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 66% 65 – 75% 3) ROIC* 5.0% 9.9% 15% 4) Adjusted EPS Growth N/A 40% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period (Est. in 2012) PolyOne Corporation Page 10 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue CAGR PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity* Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 *Pipeline as of May 29, 2014 as presented during our Innovation Day PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of June 30, 2014 Debt Maturities & Pension Funding – 6/30/14 Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of June 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 6/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.8 million shares in Q2 2014 Repurchased 8.2 million shares since early 2013  11.8 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

• The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward‐looking statements, whether as a result of new information, future events or otherwise.   The non‐GAAP financial measures  i l d dj t d EPS i b f i t t t d i ti dinclude: adjusted EPS, earnings before interest, tax, depreciation and  amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating  income, Specialty platform gross margin percentage, adjusted operating income,  return on invested capital, net debt/ EBITDA, and the exclusion of corporate p p charges in certain calculations.  EPS: $1.20 Proforma Debt Maturities & Liquidity Summary – 12/31/12 (Reflecting  Financing & Spartech Acquisition) • Total Debt at 12/31/12 h $1,010 $297 $360 $300 $400 Debt Maturities  As of December  31, 2012  ($ millions) Less: Cash Net Debt 213 $797 $50 $297 $100 $200 • Available Liquidity Cash $213 $800 Debt Maturities  As of December  31, 2012 P f f 2/13 Fi i $50 $0 2015 2017 2020 Interest Rates: 7.500%                       5.000%                      7.375% Cash ABL Availability Total Liquidity $213 271 $484 $600 $400 $600 Proforma for 2/13 Financing ($ millions) Total Liquidity • Net Debt / EBITDA = 2.0x* $484 $50 $360 $0 $200 • Net Debt / EBITDA = 2.35x** $50$0 2015 2020 2023 Page 14 Interest Rates:   7.500%                      7.375%                      5.250% *Assumes $65 million of synergies related to Spartech acquistion **Assumes no synergies related to Spartech acquistion Use of Cash Share DividendsOrganic G Acquisitions • Repurchased 1 2 Repurchase • Introduced a Dividends • Expanding our Growth T t th t d Acquisitions • Repurchased 1.2 million shares in 2012 • 20.0 million shares are il bl f • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Expanding our sales, marketing, and technical capabilities is top priority • Investing in • Targets that expand our: • Specialty offering • End market presence • Geographic footprint available for repurchase under the current authorization Q1 2013 (20%) • Objective of maintaining and growing Investing in operational and LSS initiatives (including synergy capture) • CAPEX • Synergy opportunities • Adjacent material solutions Proforma Cash Balance = $213M N t D bt / EBITDA* 2 0X CAPEX Net Debt / EBITDA* = 2.0X *Adjusted EBITDA assumes synergies related to the Spartech acquisition are realized at close; preliminary synergies estimated at $65M and are expected to be achieved over a 3-year period Page 15 Why Invest In PolyOne?

Kalol, India 65. Pune, India(d) 66. Rania, India 67.

Kalol, India 65. Pune, India(d) 66. Rania, India 67.

The company noted sales growth in nearly all end markets, as it continues to more than offset inflation to deliver record results. The above list of factors is not exhaustive. Three Months Ended March 31, 2022 2021 GAAP Results Special Items Adjusted Results GAAP Results Special Items Adjusted Results $111.1 $ 7.7 $ 118.8 $102.6 $ 2.4 $ 105.0 Income tax expense - GAAP (26.6) — (26.6) (22.9) — (22.9) Income tax impact of special items (Attachment 3) — (2.0) (2.0) — (0.9) (0.9) Tax adjustments (Attachment 3) — 1.5 1.5 — 1.1 1.1 Income tax (expense) benefit $ (26.6) $ (0.5) $ (27.1) $ (22.9) $ 0.2 $ (22.7) Effective Tax Rate(1) 23.9 % 22.8 % 22.3 % 21.6 % (1) Rates may not recalculate from figures presented herein due to rounding 12 Reconciliation of EBITDA by Segment Three Months Ended March 31, 2022 2021 Operating income: Color, Additives and Inks $ 94.5 $ 88.8 Specialty Engineered Materials 39.7 34.2 Distribution 24.2 24.0 Corporate and eliminations (29.8) (26.6) Operating income $ 128.6 $ 120.4 Items below OI in Corporate: Other income, net $ (0.6) $ 1.5 Depreciation & amortization: Color, Additives and Inks $ 26.0 $ 27.4 Specialty Engineered Materials 7.8 7.8 Distribution 0.2 0.2 Corporate and eliminations 3.8 1.7 Depreciation & Amortization $ 37.8 $ 37.1 EBITDA: Color, Additives and Inks $ 120.5 $ 116.2 Specialty Engineered Materials 47.5 42.0 Distribution 24.4 24.2 Corporate and eliminations (26.0) (24.9) Other income, net (0.6) 1.5 EBITDA $ 165.8 $ 159.0 EBITDA as a % of Sales: Color, Additives and Inks 18.6 % 19.1 % Specialty Engineered Materials 19.4 % 19.4 % Distribution 5.6 % 6.7 % Three Months Ended March 31, Reconciliation to EBITDA and Adjusted EBITDA: 2022 2021 Net income from continuing operations – GAAP $ 84.5 $ 79.7 Income tax expense 26.6 22.9 Interest expense 16.9 19.3 Depreciation and amortization 37.8 37.1 EBITDA $ 165.8 $ 159.0 Special items, before tax 7.7 2.4 Depreciation and amortization included in special items (2.1) (0.5) Adjusted EBITDA $ 171.4 $ 160.9 NEWS RELEASE Attachment 1

• The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations. EPS: $1.00 First Quarter Financial Highlights • 14th consecutive quarter of double digit adjusted earnings per share growth • 29 percent increase in adjusted EPS  34 percent increase in Specialty operating income  Growth from all regions  Virtually all organic growth • Strengthened our financial position Page 13 • Total Debt at 3/31/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 2.7x* $169 285 $454 $1,056 169 $887 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2013 ($ millions) Page 14 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets Debt Maturities & Liquidity Summary – 3/31/13 Cash Balance = $169M Net Debt / EBITDA* = 2.7x • Repurchased 840k shares in Q1 2013 • 19.1 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions Acquisitions *TTM with no synergies related to the Spartech acquisition Use of Cash Page 15 Why Invest In PolyOne?

• The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations. EPS: $1.00 First Quarter Financial Highlights • 14th consecutive quarter of double digit adjusted earnings per share growth • 29 percent increase in adjusted EPS  34 percent increase in Specialty operating income  Growth from all regions  Virtually all organic growth • Strengthened our financial position Page 12 • Total Debt at 3/31/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 2.7x* $169 285 $454 $1,056 169 $887 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM with no synergies related to Spartech acquisition & excludes resin assets Debt Maturities & Liquidity Summary – 3/31/13 Cash Balance = $169M Net Debt / EBITDA* = 2.7x • Repurchased 840k shares in Q1 2013 • 19.1 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions Acquisitions *TTM with no synergies related to the Spartech acquisition Use of Cash Page 14 Why Invest In PolyOne?

LoC No: 798019/2023 Page 1 of 1 Letter of Conformity Good Manufacturing Practices — Guidelines The Letter of Conformity is granted to Polyone Polymers India Private Limited Plot No. F -27, MIDC, Ranjangaon, Taluka – Shirur, Pune Maharashtra 412220 India Hold this Opinion Statement No. 798019/2023 The Organization has demonstrated that they have followed the guidelines provided for Good Manufacturing Practices as per the ICHQ7 guidelines in their organization for the following Business activity: Research and Development, Manufacture of Color additives, Concentrates and Specialty Formulations for intended use in pharma and other industries Theuns Kotze, Managing Director – IMETA Assurance Last Audit Date: 31.10.2023 BSI Group India Private Limited T: +91-4762-9000 (CIN U74899DL1999PTC101381 info.in@bsigroup.com The Mira Corporate Suites bsigroup.com/en-IN Plot 1&2, Ishwar Nagar, Mathura Road New Delhi-110065, India

Microsoft Word - PolyOne India Terms and Conditions of Sale of Products.052716.doc TERMS AND CONDITIONS These Terms and Conditions apply to the sale of Products by PolyOne Corporation and its subsidiaries. 1. All litigation concerning this contract shall occur only in the state and national courts of Pune, India, and each party consents to exclusive jurisdiction in such courts. 17. India Terms and Conditions; May 2016

Khandpur added, "On a geographic basis, all regions delivered year-over-year organic sales growth. The non-GAAP financial measures include adjusted EPS, adjusted operating income, adjusted EBITDA and adjusted EBITDA margins. The above list of factors is not exhaustive.